To further explore the molecular mechanism by which CYGB suppresses breast cancer, we used the proteomics approach of 8-plex isobaric tags for relative and absolute quantitation (iTRAQ) to examine altered pathways in MCF7 cells with stable CYGB transfection. The gene discussed is CYGB; the disease is breast carcinoma.